Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 416739, 12 pages
http://dx.doi.org/10.1155/2012/416739
Research Article

Changes in the Th1 : Th2 Cytokine Bias in Pregnancy and the Effects of the Anti-Inflammatory Cyclopentenone Prostaglandin 15-Deoxy- -Prostaglandin

1Parturition Research Group, Department of Surgery and Cancer, Institute of Reproduction and Developmental Biology, Imperial College London, W120NN London, UK
2St Mary’s Hospital, Imperial College Healthcare NHS Trust, W21NY London, UK

Received 13 January 2012; Revised 6 March 2012; Accepted 2 April 2012

Academic Editor: Noboru Uchide

Copyright © 2012 Lynne Sykes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Honest, C. A. Forbes, K. H. Durée et al., “Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling,” Health Technology Assessment, vol. 13, no. 43, pp. 1–627, 2009. View at Google Scholar · View at Scopus
  2. R. L. Goldenberg, W. W. Andrews, and J. C. Hauth, “Choriodecidual infection and preterm birth,” Nutrition Reviews, vol. 60, no. 5, pp. S19–S25, 2002. View at Google Scholar · View at Scopus
  3. L. Sykes, D. A. MacIntyre, T. G. Teoh, and P. R. Bennett, “Targeting immune activation in the prevention of pre-term labour,” European Obstetrics & Gynaecology, vol. 6, no. 2, pp. 100–106, 2011. View at Google Scholar
  4. B. H. Yoon, R. Romero, J. S. Park et al., “Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years,” American Journal of Obstetrics & Gynecology, vol. 182, no. 3, pp. 675–681, 2000. View at Google Scholar · View at Scopus
  5. E. T. Abrams and E. M. Miller, “The roles of the immune system in Women's reproduction: evolutionary constraints and life history trade-offs,” American Journal of Physical Anthropology, vol. 146, supplement 53, pp. 134–154, 2011. View at Google Scholar
  6. T. R. Mosmann and S. Sad, “The expanding universe of T-cell subsets: Th1, Th2 and more,” Immunology Today, vol. 17, no. 3, pp. 138–146, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. A. O'Garra and N. Arai, “The molecular basis of T helper 1 and T helper 2 cell differentiation,” Trends in Cell Biology, vol. 10, no. 12, pp. 542–550, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. A. O'Garra, “Cytokines induce the development of functionally heterogeneous T helper cell subsets,” Immunity, vol. 8, no. 3, pp. 275–283, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. K. M. Murphy, W. Ouyang, S. J. Szabo et al., “T helper differentiation proceeds through Stat1-dependent, Stat4-dependent and Stat4-independent phases,” Current Topics in Microbiology and Immunology, vol. 238, pp. 23–26, 1999. View at Google Scholar · View at Scopus
  10. T. G. Wegmann, H. Lin, L. Guilbert, and T. R. Mosmann, “Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?” Immunology Today, vol. 14, no. 7, pp. 353–356, 1993. View at Google Scholar · View at Scopus
  11. R. Mattsson, R. Holmdahl, A. Scheynius, F. Bernadotte, A. Mattsson, and P. H. van der Meide, “Placental MHC class I antigen expression is induced in mice following in vivo treatment with recombinant interferon-gamma,” Journal of Reproductive Immunology, vol. 19, no. 2, pp. 115–129, 1991. View at Publisher · View at Google Scholar · View at Scopus
  12. B. U. Tezabwala, P. M. Johnson, and R. C. Rees, “Inhibition of pregnancy viability in mice following IL-2 administration,” Immunology, vol. 67, no. 1, pp. 115–119, 1989. View at Google Scholar · View at Scopus
  13. G. Chaouat, A. A. Meliani, J. Martal et al., “IL-10 prevents naturally occuring fetal loss in the CBA x DBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-τ,” Journal of Immunology, vol. 154, no. 9, pp. 4261–4268, 1995. View at Google Scholar · View at Scopus
  14. R. Druckmann and M. A. Druckmann, “Progesterone and the immunology of pregnancy,” Journal of Steroid Biochemistry and Molecular Biology, vol. 97, no. 5, pp. 389–396, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Lin, T. R. Mosmann, L. Guilbert, S. Tuntipopipat, and T. G. Wegmann, “Synthesis of T helper 2-type cytokines at the maternal-fetal interface,” Journal of Immunology, vol. 151, no. 9, pp. 4562–4573, 1993. View at Google Scholar · View at Scopus
  16. M. Marzi, A. Vigano, D. Trabattoni et al., “Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy,” Clinical and Experimental Immunology, vol. 106, no. 1, pp. 127–133, 1996. View at Google Scholar · View at Scopus
  17. J. Tranchot-Diallo, G. Gras, F. Parnet-Mathieu et al., “Modulations of cytokine expression in pregnant women,” American Journal of Reproductive Immunology, vol. 37, no. 3, pp. 215–226, 1997. View at Google Scholar · View at Scopus
  18. M. D. Bates, S. Quenby, K. Takakuwa, P. M. Johnson, and G. S. Vince, “Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss?” Human Reproduction, vol. 17, no. 9, pp. 2439–2444, 2002. View at Google Scholar · View at Scopus
  19. S. Shimada, K. Iwabuchi, E. H. Kato et al., “No difference in natural-killer-T cell population, but Th2/Tc2 predominance in peripheral blood of recurrent aborters,” American Journal of Reproductive Immunology, vol. 50, no. 4, pp. 334–339, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Raghupathy, M. Makhseed, R. Azizieh, A. Omu, M. Gupta, and R. Farhat, “Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion,” Human Reproduction, vol. 15, no. 3, pp. 713–718, 2000. View at Google Scholar · View at Scopus
  21. J. Trowsdale and A. G. Betz, “Mother's little helpers: mechanisms of maternal-fetal tolerance,” Nature Immunology, vol. 7, no. 3, pp. 241–246, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Szekeres-Bartho, A. Barakonyi, G. Par, B. Polgar, T. Palkovics, and L. Szereday, “Progesterone as an immunomodulatory molecule,” International Immunopharmacology, vol. 1, no. 6, pp. 1037–1048, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. S. A. Huber, J. Kupperman, and M. K. Newell, “Estradiol prevents and testosterone promotes Fas-dependent apoptosis in CD4+ Th2 cells by altering Bcl 2 expression,” Lupus, vol. 8, no. 5, pp. 384–387, 1999. View at Google Scholar · View at Scopus
  24. L. Xue, S. L. Gyles, F. R. Wettey et al., “Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells,” Journal of Immunology, vol. 175, no. 10, pp. 6531–6536, 2005. View at Google Scholar · View at Scopus
  25. T. Michimata, H. Tsuda, M. Sakai et al., “Accumulation of CRTH2-positive T-helper 2 and T-cytotoxic 2 cells at implantation sites of human decidua in a prostaglandin D2-mediated manner,” Molecular Human Reproduction, vol. 8, no. 2, pp. 181–187, 2002. View at Google Scholar · View at Scopus
  26. T. Shibata, M. Kondo, T. Osawa, N. Shibata, M. Kobayashi, and K. Uchida, “15-DeoxyΔ12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes,” Journal of Biological Chemistry, vol. 277, no. 12, pp. 10459–10466, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Nagata and H. Hirai, “The second PGD2 receptor CRTH2: structure, properties, and functions in leukocytes,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 69, no. 2-3, pp. 169–177, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. T. M. Lindström and P. R. Bennett, “15-Deoxy-Δ12,14-prostaglandin J2 inhibits interleukin-1β-induced nuclear factor-κB in human amnion and myometrial cells: mechanisms and implications,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 6, pp. 3534–3543, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Pirianov, S. N. Waddington, T. M. Lindström, V. Terzidou, H. Mehmet, and P. R. Bennett, “The cyclopentenone 15-deoxy-Δ12,14-prostaglandin J2 delays lipopolysaccharide-induced preterm delivery and reduces mortality in the newborn mouse,” Endocrinology, vol. 150, no. 2, pp. 699–706, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. S. A. McCracken, E. Gallery, and J. M. Morris, “Pregnancy-specific down-regulation of NF-κB expression in T cells in humans is essential for the maintenance of the cytokine profile required for pregnancy success,” Journal of Immunology, vol. 172, no. 7, pp. 4583–4591, 2004. View at Google Scholar · View at Scopus
  31. K. A. Hadfield, S. A. McCracken, A. W. Ashton, T. G. Nguyen, and J. M. Morris, “Regulated suppression of NF-κB throughout pregnancy maintains a favourable cytokine environment necessary for pregnancy success,” Journal of Reproductive Immunology, vol. 89, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. P. B. Medawar, “Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates,” Symposia of the Society for Experimental Biology, vol. 7, pp. 320–338, 1953. View at Google Scholar
  33. S. Zourbas, S. Dubanchet, J. Martal, and G. Chaouat, “Localization of pro-inflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines at the foetomaternal interface during murine pregnancy,” Clinical and Experimental Immunology, vol. 126, no. 3, pp. 519–528, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Keski-Nisula, M. R. Hirvonen, M. Roponen, S. Heinonen, and J. Pekkanen, “Maternal and neonatal IL-4 and IFN-gamma production at delivery and 3 months after birth,” Journal of Reproductive Immunology, vol. 60, no. 1, pp. 25–33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Reinhard, A. Noll, H. Schlebusch, P. Mallmann, and A. V. Ruecker, “Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes,” Biochemical and Biophysical Research Communications, vol. 245, no. 3, pp. 933–938, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. V. C. Allport, D. Pieber, D. M. Slater, R. Newton, J. O. White, and P. R. Bennett, “Human labour is associated with nuclear factor-κB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal',” Molecular Human Reproduction, vol. 7, no. 6, pp. 581–586, 2001. View at Google Scholar · View at Scopus
  37. N. R. Chapman, G. N. Europe-Finner, and S. C. Robson, “Expression and deoxyribonucleic acid-binding activity of the nuclear factor κB family in the human myometrium during pregnancy and labor,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5683–5693, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. G. L. Veith and G. E. Rice, “Interferon gamma expression during human pregnancy and in association with labour,” Gynecologic and Obstetric Investigation, vol. 48, no. 3, pp. 163–167, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Young, A. J. Thomson, M. Ledingham, F. Jordan, I. A. Greer, and J. E. Norman, “Immunolocalization of proinflammatory cytokines in myometrium, cervix, and fetal membranes during human parturition at term,” Biology of Reproduction, vol. 66, no. 2, pp. 445–449, 2002. View at Google Scholar · View at Scopus
  40. S. J. Fortunato, R. P. Menon, K. F. Swan, and R. Menon, “Inflammatory cytokine (interleukins 1, 6, and 8 and tumor necrosis factor-α) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations,” American Journal of Obstetrics & Gynecology, vol. 174, no. 6, pp. 1855–1862, 1996, discussion 1861-1862. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Matthiesen, C. Ekerfelt, G. Berg, and J. Ernerudh, “Increased numbers of circulating interferon-γ- and interleukin-4-secreting cells during normal pregnancy,” American Journal of Reproductive Immunology, vol. 39, no. 6, pp. 362–367, 1998. View at Google Scholar · View at Scopus
  42. L. Matthiesen, M. Khademi, C. Ekerfelt et al., “In-situ detection of both inflammatory and anti-inflammatory cytokines in resting peripheral blood mononuclear cells during pregnancy,” Journal of Reproductive Immunology, vol. 58, no. 1, pp. 49–59, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Nagata, K. Tanaka, K. Ogawa et al., “Selective expression of a novel surface molecule by human Th2 cells in vivo,” Journal of Immunology, vol. 162, no. 3, pp. 1278–1286, 1999. View at Google Scholar · View at Scopus
  44. H. Tsuda, T. Michimata, M. Sakai, K. Nagata, M. Nakamura, and S. Saito, “A novel surface molecule of Th2- and Tc2-type cells, CRTH2 expression on human peripheral and decidual CD4+ and CD8+ T cells during the early stage of pregnancy,” Clinical and Experimental Immunology, vol. 123, no. 1, pp. 105–111, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. R. J. A. Helliwell, J. A. Keelan, K. W. Marvin et al., “Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 2, pp. 597–606, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Jawerbaum, E. Capobianco, C. Pustovrh et al., “Influence of peroxisome proliferator-activated receptor γ activation by its endogenous ligand 15-deoxy Δ12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women,” Molecular Human Reproduction, vol. 10, no. 9, pp. 671–676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Fukushima, “Prostaglandin J2—anti-tumour and anti-viral activities and the mechanisms involved,” Eicosanoids, vol. 3, no. 4, pp. 189–199, 1990. View at Google Scholar · View at Scopus
  48. S. W. Chung, B. Y. Kang, and T. S. Kim, “Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands: involvement of physical association between PPAR-γ and the nuclear factor of activated T cells transcription factor,” Molecular Pharmacology, vol. 64, no. 5, pp. 1169–1179, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Ricote, A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass, “The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation,” Nature, vol. 391, no. 6662, pp. 79–82, 1998. View at Publisher · View at Google Scholar · View at Scopus
  50. S. A. McCracken, C. L. Drury, H. S. Lee, and J. M. Morris, “Pregnancy is associated with suppression of the nuclear factor κB/I κB activation pathway in peripheral blood mononuclear cells,” Journal of Reproductive Immunology, vol. 58, no. 1, pp. 27–47, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. E. Cernuda-Morollón, E. Pineda-Molina, F. Javier Cañada, and D. Pérez-Sala, “15-Deoxy-Δ12,14-prostaglandin J2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit,” Journal of Biological Chemistry, vol. 276, no. 38, pp. 35530–35536, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Rossi, P. Kapahi, G. Natoli et al., “Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase,” Nature, vol. 403, no. 6765, pp. 103–108, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. D. S. Straus, G. Pascual, M. Li et al., “15-deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 9, pp. 4844–4849, 2000. View at Google Scholar
  54. B. C. Choi, K. Polgar, L. Xiao, and J. A. Hill, “Progesterone inhibits in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss,” Human Reproduction, vol. 15, supplement 1, pp. 46–59, 2000. View at Google Scholar · View at Scopus
  55. R. Raghupathy, E. Al Mutawa, M. Makhseed, F. Azizieh, and J. Szekeres-Bartho, “Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage,” BJOG, vol. 112, no. 8, pp. 1096–1101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Yamada, M. Morikawa, I. Furuta et al., “Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood,” American Journal of Reproductive Immunology, vol. 49, no. 2, pp. 84–89, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Raghupathy, E. Al-Mutawa, M. Al-Azemi, M. Makhseed, F. Azizieh, and J. Szekeres-Bartho, “Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery,” Journal of Reproductive Immunology, vol. 80, no. 1-2, pp. 91–99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. J. R. Wilczynski, “Th1/Th2 cytokines balance—yin and yang of reproductive immunology,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 122, no. 2, pp. 136–143, 2005. View at Google Scholar
  59. M. Makhseed, R. Raghupathy, S. El-Shazly, F. Azizieh, J. A. Al-Harmi, and M. M. K. Al-Azemi, “Pro-inflammatory maternal cytokine profile in preterm delivery,” American Journal of Reproductive Immunology, vol. 49, no. 5, pp. 308–318, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. F. Ni Chuileannain and S. Brennecke, “Prediction of preterm labour in multiple pregnancies,” Bailliere's Clinical Obstetrics and Gynaecology, vol. 12, no. 1, pp. 53–66, 1998. View at Publisher · View at Google Scholar · View at Scopus
  61. H. A. Alexander, S. R. Sooranna, L. Myatt, and M. R. Johnson, “Myometrial tumor necrosis factor-α receptors increase with gestation and labor and modulate gene expression through mitogen-activated kinase and nuclear factor-κB,” Reproductive Sciences, vol. 19, no. 1, pp. 43–54, 2012. View at Google Scholar
  62. R. Romero, D. T. Brody, E. Oyarzun et al., “Infection and labor. III. Interleukin-1: a signal for the onset of parturition,” American Journal of Obstetrics & Gynecology, vol. 160, no. 5, pp. 1117–1123, 1989. View at Google Scholar · View at Scopus
  63. D. W. Sadowsky, K. M. Adams, M. G. Gravett, S. S. Witkin, and M. J. Novy, “Preterm labor is induced by intraamniotic infusions of interleukin-1β and tumor necrosis factor-α but not by interleukin-6 or interleukin-8 in a nonhuman primate model,” American Journal of Obstetrics & Gynecology, vol. 195, no. 6, pp. 1578–1589, 2006. View at Publisher · View at Google Scholar · View at Scopus